Suppr超能文献

多巴胺、去甲肾上腺素和异丙肾上腺素:对小鼠胰腺的体外分泌及电生理效应

Dopamine, noradrenaline and isoprenaline: secretory and electrophysiological effects in vitro on mouse pancreas.

作者信息

Berger Z, Laugier R

出版信息

J Physiol. 1986 Jul;376:359-75. doi: 10.1113/jphysiol.1986.sp016158.

Abstract

The amylase release from mouse pancreatic fragments was studied after dopamine (DA), and alpha- or beta-sympathomimetic agonist application. The electrical parameters of the acinar cell membrane were also monitored. Both DA (from 5 X 10(-6) to 10(-4) M) and beta-stimulants (isoprenaline from 5 X 10(-6) to 5 X 10(-5) M; noradrenaline from 3 X 10(-4) to 10(-3) M) evoked an increase in amylase release, while noradrenaline in alpha-receptor stimulating doses failed to have any effect. The stimulatory effect of DA was blocked by ganglion blockers (Arfonad 10(-5) M; pentamethonium 3 X 10(-5) M) in a competitive manner and a dual antagonism was observed with atropine (10(-7) M, 10(-9) M). An alpha-receptor antagonist (phentolamine 10(-5) M) and a beta-receptor antagonist (propranolol 10(-5) M) had no influence on the dopamine response. Moreover, the DA-induced stimulation was dependent on the presence of extracellular calcium. Perfusion with 10(-4) and 10(-3) M-DA or local application (from 77 micrograms to 4.3 mg), resulted in marked membrane depolarization with diminution of the input resistance. This effect was blocked by atropine (10(-5) M) and pentamethonium (10(-4) M), but not by propranolol (10(-5) M) or phentolamine (10(-5) M). The isoprenaline- (IP) and noradrenaline- (NA) induced increase in amylase release was competitively blocked by propranolol (10(-5) M) but not by phentolamine (10(-5) M). Atropine caused a dose-dependent (10(-7) M, 10(-6) M) decrease in the maximal response (non-competitive antagonism), while the ganglion blocker pentamethonium (10(-4) M) was without effect. NA caused membrane depolarization accompanied by a decrease in the input resistance after local application (from 77 micrograms to 1.6 mg). This effect persisted in the presence of 10(-5) M-phentolamine but was abolished by 10(-5) M-propranolol. IP perfusion (10(-4) and 10(-3) M) or local application (0.3 M; from 32 to 130 micrograms) caused the same electrical changes as those induced by NA and DA. The effect of IP persisted in the presence of 10(-5) M-phentolamine, 10(-4) M-pentamethonium and 10(-4) M-domperidone, but was abolished by propranolol (10(-5) M) and tetrodotoxin (5 X 10(-6) M) and markedly diminished by atropine (10(-5) M).(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在应用多巴胺(DA)、α或β肾上腺素能激动剂后,研究了小鼠胰腺碎片淀粉酶的释放情况。同时也监测了腺泡细胞膜的电参数。DA(浓度从5×10⁻⁶到10⁻⁴M)和β激动剂(异丙肾上腺素浓度从5×10⁻⁶到5×10⁻⁵M;去甲肾上腺素浓度从3×10⁻⁴到10⁻³M)均能引起淀粉酶释放增加,而去甲肾上腺素在刺激α受体的剂量下则无任何作用。DA的刺激作用可被神经节阻滞剂(阿方那特10⁻⁵M;五甲溴铵3×10⁻⁵M)竞争性阻断,且观察到与阿托品(10⁻⁷M、10⁻⁹M)存在双重拮抗作用。α受体拮抗剂(酚妥拉明10⁻⁵M)和β受体拮抗剂(普萘洛尔10⁻⁵M)对多巴胺反应无影响。此外,DA诱导的刺激依赖于细胞外钙的存在。用10⁻⁴和10⁻³M - DA灌注或局部应用(从77微克到4.3毫克),会导致明显的膜去极化,输入电阻降低。这种效应可被阿托品(10⁻⁵M)和五甲溴铵(10⁻⁴M)阻断,但不能被普萘洛尔(10⁻⁵M)或酚妥拉明(10⁻⁵M)阻断。异丙肾上腺素(IP)和去甲肾上腺素(NA)诱导的淀粉酶释放增加可被普萘洛尔(10⁻⁵M)竞争性阻断,但不能被酚妥拉明(10⁻⁵M)阻断。阿托品导致最大反应呈剂量依赖性(10⁻⁷M、10⁻⁶M)降低(非竞争性拮抗),而神经节阻滞剂五甲溴铵(10⁻⁴M)则无作用。NA局部应用(从77微克到1.6毫克)后会导致膜去极化,同时输入电阻降低。在存在10⁻⁵M酚妥拉明的情况下,这种效应持续存在,但被10⁻⁵M普萘洛尔消除。IP灌注(10⁻⁴和10⁻³M)或局部应用(0.3M;从32到130微克)引起的电变化与NA和DA诱导的变化相同。IP的效应在存在10⁻⁵M酚妥拉明、10⁻⁴M五甲溴铵和10⁻⁴M多潘立酮的情况下持续存在,但被普萘洛尔(10⁻⁵M)和河豚毒素(5×10⁻⁶M)消除,并被阿托品(10⁻⁵M)显著减弱。(摘要截断于400字)

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验